PIK3CA and colorectal carcinoma: In addition to tumors exhibiting irinotecan resistance and combination sensitivity, we identified an association ( p = 0.02– 2 × 2 fisher exact test- data not shown) between PIK3CA mutation and combination sensitivity when we combined CRC cell lines and PDX models.